A Phase 1, Open-label, Multi-Dose Study to Assess Pharmacokinetic Interaction Between PA-824 and Midazolam
Latest Information Update: 26 Jun 2014
At a glance
- Drugs Midazolam (Primary) ; Pretomanid (Primary)
- Indications Anxiety disorders; Bacterial infections; Sleep disorders; Tuberculosis
- Focus Adverse reactions; Pharmacokinetics
- 27 Jan 2013 New trial record